• ADA Announces Interim Opioids Policy.

    The ADA News (3/26, Garvin) reports the Association announced on March 26 a new interim policy on opioids that supports mandatory continuing education for dentists, prescription limits, and utilization of prescription drug monitoring programs. Titled Interim Board Policy on Opioid Prescribing, the new policy is thought to be the first of its kind among major health professional organizations. “I call upon dentists everywhere to double down on their efforts to prevent opioids from harming our patients and their families,” said ADA President Joseph P. Crowley. “This new policy demonstrates the ADA’s firm commitment to help fight the country’s opioid epidemic while continuing to help patients manage dental pain.”

    In a second article, the ADA News (3/26, Garvin) reports that “the April issue of The Journal of the American Dental Association focuses on the subject of opioids and dentistry.” The four cover articles examine opioid prescribing patterns among US dentists; disparities in opioid prescriptions for Medicaid dental patients; the benefits and adverse events associated with acute pain relief from opioids and nonsteroidal anti-inflammatory drugs; and prescription monitoring programs.

    Also reporting are CBS News (3/26, Strickler), the Associated Press (3/26, Tanner), The Hill (3/26, Roubein), UPI (3/26, Brokaw), and Dr Bicuspid (3/26, Edwards).

    For more information about opioids, including upcoming webinars and subscriber tips, visit